|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to PEG-Intron (Peginterferon Alfa-2B). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (992)
Cases resulting in a serious event (987)
Cases resulting in death (58)
Cases resulting in life threatening events (52)
Cases resulting in hospitalization (563)
Cases resulting in disability (43)
Cases resulting in other serious reactions (582)
Below is a sample of reports where side effects / adverse reactions may be related to PEG-Intron (Peginterferon Alfa-2B). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 50 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from Japan on 2007-10-31
Patient: 50 year old male
Adverse reactions / side effects: Haemoptysis
Suspect drug(s):
PEG-Intron
Dosage: 100 mg qw sc
Indication: Hepatitis C
Start date: 2007-09-21
Rebetol
Dosage: 800 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-09-21
Other drugs received by patient: Urso 250; Glycyron
Adverse event in 49 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 49 year old female, weighing 74.8 kg (164.7 pounds)
Adverse reactions / side effects: Agitation, Oral Intake Reduced, Drug Ineffective, Visual Acuity Reduced, Headache, Pyrexia, Constipation, Fall, Abdominal Discomfort, Fatigue, Photophobia, Abdominal Distension, Depression, Vomiting, Nausea, Paraesthesia, Haematochezia, Insomnia, Alopecia, Dehydration, Anorexia, Memory Impairment, Lacrimation Increased, Asthenia
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2007-08-07
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-08-07
Other drugs received by patient: Laxatives
Adverse event in 54 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 54 year old male
Adverse reactions / side effects: Blood Iron Decreased, White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Ascites, Hepatic Cirrhosis
Suspect drug(s):
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2007-08-31
End date: 2007-10-24
Ribavirin
Dosage: po
Administration route: Oral
Indication: Hepatitis
Start date: 2007-08-31
End date: 2007-10-24
Adverse event in male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from France on 2007-10-31
Patient: male, weighing 66.0 kg (145.2 pounds)
Adverse reactions / side effects: Refusal of Treatment by Patient, Tuberculosis, Malignant Histiocytosis, Metastases TO Lung
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron (Peginterferon Alfa-2B)
Adverse event in 52 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 52 year old female, weighing 70.3 kg (154.7 pounds)
Adverse reactions / side effects: Weight Decreased, Muscle Atrophy, Fall, Thinking Abnormal, Road Traffic Accident, Fatigue, Mood Altered, Balance Disorder, DRY Mouth, Dizziness, Brain Oedema, Depression, Hydrocephalus, Urinary Retention, Crying, Vomiting, Nausea, Anxiety, Anorexia, Memory Impairment, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2006-11-02
End date: 2007-09-06
Ribavirin
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-11-02
End date: 2007-09-06
Other drugs received by patient: Vicodin (Con.); Clonazepam (Con.); Corgard (Con.); Cymbalta (Con.); Fiorinal (Con.); Glyburide (Con.); Hyoscyamine (Con.); Lipitor (Con.); Meclizine (Con.); Metformin (Con.); Nexium (Con.); Promethazine (Con.); Singulair (Con.); Ibuprofen (Con.)
Adverse event in 55 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from Japan on 2007-10-31
Patient: 55 year old male
Adverse reactions / side effects: Haemoglobin Decreased, Cellulitis, Vitreous Haemorrhage
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 100 mcg qw sc
Indication: Hepatitis C
Start date: 2006-03-13
End date: 2006-12-27
Rebetol
Dosage: 600 mg qd po ; 500 mg qd po ; 400 mg qd po ; 600 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-13
End date: 2006-04-26
Rebetol
Dosage: 600 mg qd po ; 500 mg qd po ; 400 mg qd po ; 600 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-04-27
End date: 2006-05-10
Rebetol
Dosage: 600 mg qd po ; 500 mg qd po ; 400 mg qd po ; 600 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-05-11
End date: 2006-06-27
Rebetol
Dosage: 600 mg qd po ; 500 mg qd po ; 400 mg qd po ; 600 mg qd po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-08-28
End date: 2007-01-03
Other drugs received by patient: Glyburide; Glucobay; Melbin; Voltaren; Jeoase; Cacelmin
Adverse event in female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from United States on 2007-10-30
Patient: female, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Dyspnoea
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Indication: Hepatitis C
Start date: 2007-06-04
End date: 2007-07-30
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-06-04
End date: 2007-08-03
Other drugs received by patient: Imodium; Ibuprofen; Ibuprofen; Multi-Vitamins; Nicoderm; Modafinil; Zyrtec; Cymbalta; Propranolol; Propranolol; Conjugated Estrogens; Lisinopril; Nexium; Eszopiclone; Propoxyphene Hydrochloride; Skelaxin; Balsalazide Disodium; Imitrex; Promethazine HCL
Adverse event in 41 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 41 year old male
Adverse reactions / side effects: Migraine, Fatigue, Malaise, Renal Failure, Chills, Respiratory Arrest, Loss of Consciousness
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2007-08-03
Ribasphere
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-08-03
Adverse event in 38 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from Japan on 2007-10-29
Patient: 38 year old male
Adverse reactions / side effects: Autoimmune Hepatitis, Hepatitis C RNA Positive, Condition Aggravated, Chronic Hepatitis, Liver Disorder
Suspect drug(s):
PEG-Intron
Dosage: ; qw; sc
Indication: Hepatitis C
Start date: 2004-12-16
End date: 2005-06-20
Peginterferon Alfa-2A (Peginterferon Alfa-2A)
Indication: Hepatitis C
Start date: 2005-01-01
End date: 2006-01-01
Rebetol
Dosage: ; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2004-12-16
End date: 2005-06-20
Adverse event in 56 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 56 year old female, weighing 55.8 kg (122.7 pounds)
Adverse reactions / side effects: Dysgeusia, Weight Decreased, Malaise, Euphoric Mood, Retching, Dehydration, Memory Impairment, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;qw
Indication: Hepatitis C
Start date: 2007-04-03
End date: 2007-04-17
Rebetol
Dosage: 200 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-04-03
End date: 2007-04-17
Adverse event in 59 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 59 year old female, weighing 72.6 kg (159.7 pounds)
Adverse reactions / side effects: Agitation, Oral Intake Reduced, Performance Status Decreased, Weight Decreased, Headache, Constipation, Oral Herpes, Impaired Driving Ability, Hot Flush, Malaise, Road Traffic Accident, Anger, Vomiting, Anaemia, Condition Aggravated, Cystitis, Emotional Distress, Incoherent, Dysuria, Insomnia, Dehydration, Hypertension, Aphonia, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2007-05-01
End date: 2007-08-16
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-05-01
End date: 2007-08-16
Adverse event in 51 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 51 year old female, weighing 81.6 kg (179.6 pounds)
Adverse reactions / side effects: Weight Decreased, Hepatic Pain, Vomiting, Nausea, Pain in Extremity, Pain, Pleurisy, Hepatic Neoplasm, Food Aversion, Weight Fluctuation, Decreased Appetite, Influenza Like Illness
Suspect drug(s):
PEG-Intron
Dosage: ; sc
Indication: Hepatitis C
Start date: 2007-07-06
Rebetol
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-07-06
Adverse event in 53 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 53 year old female, weighing 77.1 kg (169.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Weight Decreased, Aphasia, Hypoglycaemia, Headache, Constipation, Loss of Consciousness, Fatigue, Injection Site Erythema, Oedema Peripheral, Blindness Unilateral, Abdominal Distension, Blindness Transient, Mood Swings, Crying, White Blood Cell Count Decreased, Vomiting, Angina Pectoris, Nausea, Anaemia, Injection Site Pruritus, Eye Pain, Tremor, Anxiety, Increased Tendency TO Bruise, Insomnia, Asthenia, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: ;sc
Indication: Hepatitis C
Start date: 2007-04-06
Ribavirin
Dosage: ;po
Administration route: Oral
Indication: Hepatitis
Start date: 2007-04-06
Other drugs received by patient: Antidepressants; Pain Medication; Inhaler
Adverse event in 60 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from Japan on 2007-10-29
Patient: 60 year old male
Adverse reactions / side effects: Autoimmune Disorder, Hepatic Function Abnormal, Drug Hypersensitivity, Oedema Peripheral, Platelet Count Decreased, Pleural Effusion, Transaminases Increased, Ascites
Adverse event resulted in: hospitalization
Suspect drug(s):
Intron A
Dosage: 10 miu; im
Indication: Hepatitis C
PEG-Intron
Dosage: 100 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-01-01
Rebetol
Dosage: po; 800 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-01-01
Other drugs received by patient: Stronger NEO Minophagen C
Adverse event in 41 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: 41 year old female
Adverse reactions / side effects: Thrombosis, Pneumonia, Haemoptysis, Anaemia, Wegener's Granulomatosis, Pulmonary Embolism, Pulmonary Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 150 mcg; qw; sc
Indication: Hepatitis C
Start date: 2004-07-01
End date: 2004-10-30
Ribavirin
Dosage: 6 df; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2004-07-01
End date: 2004-11-02
Other drugs received by patient: Liquibid; Maxzide; Bextra; Tylenol (Caplet); Tums; Ibuprofen; Augmentin '125'; Unspecified Therapeutic Agent
Adverse event in 41 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from United States on 2007-10-29
Patient: 41 year old female
Adverse reactions / side effects: Pelvic Inflammatory Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 96 mcg;qd;sc; 48 mcg; ;sc
Indication: Chronic Hepatitis
Start date: 2004-06-15
End date: 2004-07-05
PEG-Intron
Dosage: 96 mcg;qd;sc; 48 mcg; ;sc
Indication: Chronic Hepatitis
Start date: 2004-07-06
Viramidine
Dosage: ;bid;po
Indication: Hepatitis C
Start date: 2004-06-15
Other drugs received by patient: Tylenol (Caplet); Ciprofloxacin
Adverse event in 65 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from Japan on 2007-10-29
Patient: 65 year old male, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Pancreatitis Acute, Lupus-Like Syndrome, Disseminated Intravascular Coagulation, Glomerulonephritis Membranoproliferative, Cholestasis, Hepatic Failure, Serositis, Bone Marrow Failure, Pulmonary Alveolar Haemorrhage, Anaemia, Condition Aggravated, Autoimmune Disorder, Renal Failure, Respiratory Failure, Sepsis, Insomnia, Systemic Lupus Erythematosus, NO Therapeutic Response, Lupus Nephritis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Suspect drug(s):
PEG-Intron
Dosage: 100 mcg;qw;sc
Indication: Hepatitis C
Start date: 2005-03-09
End date: 2005-12-20
Rebetol
Dosage: 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2005-03-09
End date: 2005-12-26
Other drugs received by patient: Urso 250
Adverse event in 60 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from United States on 2007-10-29
Patient: 60 year old female, weighing 63.5 kg (139.7 pounds)
Adverse reactions / side effects: Peritonitis Bacterial
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 30 mcg;qw;sc
Indication: Hepatitis C
Start date: 2007-09-18
End date: 2007-10-17
Procrit
Dosage: 40000 iu;qw;sc
Indication: Anaemia
Start date: 2007-10-09
End date: 2007-10-17
Rebetol
Dosage: 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-09-18
End date: 2007-10-17
Other drugs received by patient: Lasix; Aldactone; Qualaquin; Aciphex; Clonipine; Milk Thistle
Adverse event in male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from United States on 2007-10-29
Patient: male, weighing 116.0 kg (255.2 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Adverse event resulted in: disablity
Suspect drug(s):
HCV-796
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
PEG-Intron
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-03-21
Rebetol
Administration route: Oral
Start date: 2007-03-21
End date: 2007-07-09
Other drugs received by patient: Omeprazole; Allopurinol; Compazine; Compazine; Levothyroxine Sodium; Lorazepam; Folic Acid; Fentanyl Citrate; Atenolol
Adverse event in receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient:
Adverse reactions / side effects: Amyloidosis
Suspect drug(s):
PEG-Intron
Dosage: ;sc
Indication: Drug USE FOR Unknown Indication
Ribavirin
Dosage: ;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 48 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient: 48 year old male
Adverse reactions / side effects: Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Ocular Icterus, Hepatic Enzyme Increased
Suspect drug(s):
HCV-796
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-27
End date: 2007-08-10
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2006-12-27
End date: 2007-08-28
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-27
End date: 2007-08-28
Other drugs received by patient: Effexor (Con.); Acetaminophen (Con.); Riboflavin (Con.); Vitamin B (Con.); Iron (Con.); Metronidazole (Con.)
Adverse event in 50 year old female receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 50 year old female
Adverse reactions / side effects: Oral Mucosal Blistering, White Blood Cell Count Decreased, Pruritus, Neoplasm Malignant, Impaired Healing, Skin Necrosis, Erythema, Blister
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;
Indication: Hepatitis C
Start date: 2007-06-01
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-06-01
Adverse event in 44 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 44 year old male, weighing 107.0 kg (235.5 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Weight Decreased, Nightmare, LIP DRY, Chapped Lips, Headache, Hyperhidrosis, Malaise, Hallucination, Visual, Insomnia, Dehydration, Platelet Count Decreased, Anger, Dizziness
Suspect drug(s):
PEG-Intron
Dosage: ; sc
Indication: Hepatitis C
Start date: 2007-07-12
End date: 2007-10-16
Ribavirin
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-07-12
End date: 2007-10-16
Zolpidem Tartrate
Indication: Insomnia
Adverse event in 47 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a consumer/non-health professional from United States on 2007-10-25
Patient: 47 year old male
Adverse reactions / side effects: White Blood Cell Count Decreased, RED Blood Cell Count Decreased, Haematemesis, Influenza Like Illness
Suspect drug(s):
PEG-Intron
Dosage: ; sc
Indication: Hepatitis C
Rebetol
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Adverse event in 67 year old male receiving PEG-Intron (Peginterferon Alfa-2B)
Reported by a physician from Japan on 2007-10-25
Patient: 67 year old male, weighing 64.0 kg (140.8 pounds)
Adverse reactions / side effects: Acute Pulmonary Oedema, Pneumonia, Anaemia, Hepatic Failure, Condition Aggravated, Blood Beta-D-Glucan Increased, Hepatic Atrophy, Respiratory Failure, Staphylococcal Infection, Blood Culture Positive, Sepsis, Acute Respiratory Distress Syndrome, Cytomegalovirus Infection, Platelet Count Decreased, Enteritis Infectious, Infection
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 80 mcg; qw; sc; 50 mcg; qw; sc; 40 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-03-13
End date: 2006-03-20
PEG-Intron
Dosage: 80 mcg; qw; sc; 50 mcg; qw; sc; 40 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-03-27
End date: 2006-04-03
PEG-Intron
Dosage: 80 mcg; qw; sc; 50 mcg; qw; sc; 40 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-04-10
End date: 2006-12-19
Rebetol
Dosage: 800 mg; qd; po; 600 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-13
End date: 2006-03-26
Rebetol
Dosage: 800 mg; qd; po; 600 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-27
End date: 2006-12-26
|
